Allscripts Healthcare Solutions Inc (MDRX) Position Maintained by Cambridge Advisors Inc.

Cambridge Advisors Inc. maintained its stake in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) during the first quarter, Holdings Channel reports. The fund owned 14,200 shares of the software maker’s stock at the end of the first quarter. Cambridge Advisors Inc.’s holdings in Allscripts Healthcare Solutions were worth $180,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Sciencast Management LP bought a new stake in Allscripts Healthcare Solutions during the fourth quarter valued at approximately $103,000. Riverhead Capital Management LLC boosted its stake in Allscripts Healthcare Solutions by 63.7% in the third quarter. Riverhead Capital Management LLC now owns 8,500 shares of the software maker’s stock valued at $112,000 after buying an additional 3,308 shares in the last quarter. GSA Capital Partners LLP bought a new stake in Allscripts Healthcare Solutions during the fourth quarter valued at approximately $118,000. Bank of Montreal Can boosted its stake in Allscripts Healthcare Solutions by 60.2% in the first quarter. Bank of Montreal Can now owns 9,914 shares of the software maker’s stock valued at $126,000 after buying an additional 3,724 shares in the last quarter. Finally, Two Sigma Securities LLC bought a new stake in Allscripts Healthcare Solutions during the third quarter valued at approximately $134,000.

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) traded up 0.85% during mid-day trading on Thursday, reaching $11.89. 2,266,045 shares of the company’s stock were exchanged. Allscripts Healthcare Solutions Inc has a one year low of $9.80 and a one year high of $15.17. The company’s 50-day moving average is $12.17 and its 200 day moving average is $11.69. The firm’s market capitalization is $2.15 billion.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its quarterly earnings results on Thursday, February 16th. The software maker reported $0.14 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.15 by $0.01. Allscripts Healthcare Solutions had a positive return on equity of 5.79% and a negative net margin of 0.14%. The business earned $425.40 million during the quarter, compared to analyst estimates of $424.11 million. During the same quarter last year, the company posted $0.13 EPS. Allscripts Healthcare Solutions’s quarterly revenue was up 23.1% compared to the same quarter last year. Equities analysts predict that Allscripts Healthcare Solutions Inc will post $0.62 earnings per share for the current fiscal year.

WARNING: “Allscripts Healthcare Solutions Inc (MDRX) Position Maintained by Cambridge Advisors Inc.” was first reported by WKRB News and is the sole property of of WKRB News. If you are accessing this article on another website, it was copied illegally and reposted in violation of international copyright legislation. The original version of this article can be read at https://www.wkrb13.com/markets/2065432/allscripts-healthcare-solutions-inc-mdrx-position-maintained-by-cambridge-advisors-inc.html.

Several equities research analysts have recently commented on MDRX shares. Jefferies Group LLC reaffirmed a “buy” rating and issued a $16.50 target price on shares of Allscripts Healthcare Solutions in a research report on Friday, February 17th. Dougherty & Co raised shares of Allscripts Healthcare Solutions from a “neutral” rating to a “buy” rating and set a $15.00 price target for the company in a research report on Monday, February 13th. Maxim Group lowered their price target on shares of Allscripts Healthcare Solutions from $18.00 to $16.00 and set a “buy” rating for the company in a research report on Tuesday, January 10th. Canaccord Genuity reissued a “buy” rating and set a $17.00 price target on shares of Allscripts Healthcare Solutions in a research report on Tuesday, January 3rd. Finally, Deutsche Bank AG raised shares of Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating and lifted their price target for the company from $12.50 to $14.00 in a research report on Friday, March 24th. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, eight have issued a hold rating and eleven have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $14.84.

In related news, SVP Brian Farley sold 15,000 shares of the stock in a transaction that occurred on Thursday, March 23rd. The shares were sold at an average price of $11.63, for a total value of $174,450.00. Following the transaction, the senior vice president now owns 217,861 shares in the company, valued at approximately $2,533,723.43. The sale was disclosed in a filing with the SEC, which is available through this link. 0.75% of the stock is currently owned by corporate insiders.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

5 Day Chart for NASDAQ:MDRX

Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions Inc (NASDAQ:MDRX).

This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2065432/allscripts-healthcare-solutions-inc-mdrx-position-maintained-by-cambridge-advisors-inc.html

Receive News & Ratings for Allscripts Healthcare Solutions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc and related companies with MarketBeat.com's FREE daily email newsletter.

 


Leave a Reply

 
© 2006-2017 WKRB News.